Cwm LLC Raises Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

CWM LLC boosted its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 124.5% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 95,087 shares of the medical instruments supplier's stock after purchasing an additional 52,727 shares during the quarter. CWM LLC's holdings in DENTSPLY SIRONA were worth $1,421,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Envestnet Asset Management Inc. increased its position in DENTSPLY SIRONA by 9.0% during the first quarter. Envestnet Asset Management Inc. now owns 494,737 shares of the medical instruments supplier's stock valued at $7,391,000 after acquiring an additional 40,936 shares during the last quarter. Brown Advisory Inc. bought a new position in shares of DENTSPLY SIRONA in the first quarter worth about $679,000. Comerica Bank grew its holdings in shares of DENTSPLY SIRONA by 41.2% in the fourth quarter. Comerica Bank now owns 225,080 shares of the medical instruments supplier's stock worth $4,272,000 after purchasing an additional 65,709 shares during the last quarter. Cerity Partners LLC grew its holdings in shares of DENTSPLY SIRONA by 268.5% in the fourth quarter. Cerity Partners LLC now owns 65,588 shares of the medical instruments supplier's stock worth $1,294,000 after purchasing an additional 47,788 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC grew its holdings in shares of DENTSPLY SIRONA by 39.0% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 53,903 shares of the medical instruments supplier's stock worth $805,000 after purchasing an additional 15,117 shares during the last quarter. Institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Price Performance

DENTSPLY SIRONA stock traded down $0.39 during trading on Thursday, reaching $16.46. The company had a trading volume of 2,077,441 shares, compared to its average volume of 2,528,443. The firm's 50-day simple moving average is $16.05 and its 200 day simple moving average is $16.22. DENTSPLY SIRONA Inc. has a 1-year low of $12.16 and a 1-year high of $27.95. The firm has a market capitalization of $3.28 billion, a PE ratio of -3.63, a price-to-earnings-growth ratio of 1.20 and a beta of 0.94. The company has a debt-to-equity ratio of 0.79, a quick ratio of 0.76 and a current ratio of 1.10.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.29 by $0.14. DENTSPLY SIRONA had a negative net margin of 24.42% and a positive return on equity of 14.31%. The firm had revenue of $879.00 million for the quarter, compared to analysts' expectations of $854.75 million. During the same quarter last year, the company earned $0.42 EPS. The firm's revenue for the quarter was down 7.8% compared to the same quarter last year. As a group, equities research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, July 11th. Stockholders of record on Friday, June 27th were issued a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, June 27th. This represents a $0.64 annualized dividend and a dividend yield of 3.89%. DENTSPLY SIRONA's dividend payout ratio is presently -14.10%.

Analysts Set New Price Targets

XRAY has been the topic of a number of research analyst reports. Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a report on Monday. UBS Group lowered their price objective on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating for the company in a research note on Friday, May 9th. Wall Street Zen raised shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research note on Sunday, July 13th. Barrington Research reaffirmed an "outperform" rating and issued a $21.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday. Finally, Piper Sandler lowered their price objective on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a research note on Wednesday, April 30th. Ten research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $19.60.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.